-
Liang said he recognized the U.S. desire for military-to-military ties that are uninterrupted by political disagreements.
WSJ: China Takes Hard Line With U.S. on Taiwan
-
The Securities and Exchange Commission filed civil charges against Cheng Yi Liang, 57, an FDA employee since 1996, alleging he illegally traded in advance of at least 27 different FDA announcements involving 19 publicly traded companies.
WSJ: FDA Chemist Charged With Insider Trading
-
According to court documents, officials with the Department of Health and Human Services' inspector general's office installed software on Mr. Liang's work computer that collected screen shots showing how he accessed the tracking system to follow Viibryd matters, including a document recommending approval of the drug.
WSJ: FDA Chemist Charged With Insider Trading